Consistency: Daily, moderate doses are more effective than occasional mega-doses
10.1007/s00210-024-03378-z [DOI] [PMC free article] [PubMed] [Google Scholar] Arya P
Known and novel pathways of metabolic dysfunction, previously relevant in older populations or animal models, such as transcriptional regulation, brain-derived neurotrophic factor (BDNF), nitric oxide, and renin-angiotensin pathways, have been recognized in young adults at risk for coronary issues 6
American Diabetes Associations 83rd Scientific Sessions
The FDA said in a federal notice Wednesday it will ask a panel of outside advisers to review seven peptides at a meeting in July, specifically whether they should be added to a list of substances that can be safely produced by pharmacies
Studies are underway to investigate GLP-1s and SGLT-2s as well as the kidney drug Kerendia (finerenone) as adjunctive therapies